Volume 134 Issue 26 | Blood | American Society of Hematology
Read the current issue of Blood.
Related Articles
Cardiac Events after Allo-HCT in Patients with Acute Myeloid Leukemia. Study Conducted con Behalf of the GETH-TC
Key Points. Using PTCY raised the risk of early cardiac events (CE) but did affect the likelihood of late cardiac toxicity.As CE diagnosis increased mortal
A fresh look at covalent BTK inhibitor resistance
In this issue of Blood, Woyach et al present a beautiful study of mutational profiling for patients with relapsed or refractory chronic lymphocytic leukemi
How I diagnose and treat organizing pneumonia in hematopoietic cell transplant recipients
Organizing pneumonia (OP) after allogeneic hematopoietic stem cell transplant (HCT OP) is a major cause of severe morbidity and mortality and is usually as
Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma
Key Points. Cumulative fracture incidence after R-CHOP in older patients (>70 years) is high (11.4% at 18 months).Bone involvement, prephase steroids, or eit
Bone Loss and High Bone Turnover in Patients with Non-Hodgkin’s Lymphoma Who Receive Frontline Chemotherapy: Final Results of a Multicenter Prospective Study
Introduction: Chemotherapy associated osteoporosis is a severe problem in patients with malignant diseases as it increases the risk for fractures and deteriorat
How I diagnose and treat organizing pneumonia in hematopoietic cell transplant recipients
Organizing pneumonia (OP) after allogeneic hematopoietic stem cell transplant (HCT OP) is a major cause of severe morbidity and mortality and is usually as
Procoagulant membranes during hemostasis
In this issue of Blood, Ballard-Kordeliski et al explore the intricate balance of procoagulant and fibrinolytic activities during hemostasis in vivo. Using
You Make the Call: How would you treat venous sinus thrombosis in a patient with heterozygous prothrombin mutation and on testosterone replacement? | ASH Clinical News | American Society of Hematology
Ana Casanegra, MD, MS Associate Professor of Medicine Director, Thrombosis, Anticoagulation and Thrombophilia Clinic Mayo Clinic Rochester, MN Tanna Tan, MBBCh Resident, Internal Medicine Mayo…
More is not always better
In this issue of Blood, Smith et al show that bendamustine-rituximab (BR) followed by rituximab maintenance (R) represents an effective induction regimen f
Maternal red blood cell alloimmunization prevalence in the United States
Key PointsIn this first national sample of RBC abs in pregnancies in the United States, 1.5% screened positive for RBC abs.The prevalence of RBC abs…
